Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
A phase 3 trial of Tamoxifen and Toremifene in Breast cancer, run by Chinese Anti-Cancer Association, with a status the registry has not verified recently.
Overview
Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer is a phase 3 interventional study registered as NCT03351062 by Chinese Anti-Cancer Association, with 844 participants planned, started 2017-11 and due to reach its primary completion in 2025-12. Interventions recorded: Tamoxifen, Toremifene. Conditions recorded: Breast Cancer Female.
Linked to the drug Toremifene because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialAdjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
Shares Toremifene, Breast cancer (all types) and the tag pipeline.
- TrialToremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
Shares Toremifene and the tag pipeline.
- TrialTriptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Shares Tamoxifen, Breast cancer (all types) and the tag pipeline.
- TrialHOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer
Shares Tamoxifen, Breast cancer (all types) and the tag pipeline.
- TrialCombination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
Shares Tamoxifen, Breast cancer (all types) and the tag pipeline.
- TrialInvestigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer
Shares Tamoxifen, Breast cancer (all types) and the tag pipeline.
- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.
- TrialCryoablation Versus Lumpectomy in Early-Stage Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.